Asthenopia

A double-masked, randomized, cross-over clinical study shows that patients wearing Neurolenses had improved scores on a validated headache questionnaire. DALLAS, March 5, 2024 /PRNewswire/ -- Neurolens, a company commercializing innovative solutions to provide effortless vision, announced today the results of a double-masked, crossover peer-reviewed publication demonstrating that Neurolenses provide significant relief from headaches. In this multi-site study (10 optometry practices, 195 patients), Neurolenses demonstrated a statistically significant level of impact based on the widely used and validated Headache Impact Test, or HIT-6*. These results were peer-reviewed and published by Translational Vision Science & Technology, a highly regarded medical journal published by the Association of Research in Vision and Ophthalmology (ARVO). "This is a landmark moment, not just for Neurolens, but for the entire vision industry," said Davis Corley, Neurolens CEO. "Neurolens is built on a clinical foundation, and we are pleased that a solution as simple and elegant as contoured prism lenses could expand the benefits of the annual eye exam. This study just reinforces what we already know: Neurolenses can change lives." The six-item Headache Impact Test (HIT-6) was designed to provide a global measure of adverse headache impact by assessing the adverse impact of headaches on social functioning, role functioning, vitality, cognitive functioning and psychological distress—while also measuring the severity of headache pain. Multiple studies have shown that the HIT-6 is a reliable and valid tool for measuring the impact of headaches on daily life. In effect, this demonstrates that Neurolenses provide a statistically significant improvement on the impact of headaches on patients' quality of life. "We acknowledge that double-masked, crossover peer-reviewed studies are rare in the optometry space, but clinical efficacy is at the foundation of what this organization stands for," said Dr. Jason Hurley, study author. "We were thrilled to demonstrate the impact of Neurolens, and equally thrilled to be published in Translational Vision Science & Technology, a top vision science publication." To learn more and access the full article please visit . *Efficacy & Safety have been fully evaluated and discussed in the peer-reviewed publication. About Neurolens Neurolens commercializes breakthrough technology to improve vision care. With patented Contoured Prism technology, Neurolenses are the first and only prescription lenses that go beyond visual acuity to provide comfort for the majority of adults who complain of headaches, neck/shoulder pain and eyestrain when using digital devices, reading or doing detail work. The Neurolens Contoured Prism design helps the eyes work together comfortably, bringing the eyes into alignment to relieve painful symptoms. Technology from Neurolens is only available to Independent Eye Care Providers. About Translational Vision Science & Technology Translational Vision Science & Technology is a peer-reviewed online-only open access medical journal covering ophthalmology. It was established in 2012 and is published by the Association for Research in Vision and Ophthalmology, of which it is an official journal. The editor-in-chief is Roy S. Chuck. About HIT-6 The six-item Headache Impact Test (HIT-6) was designed to provide a global measure of adverse headache impact and was developed to use in screening and monitoring patients with headaches in both clinical practice and clinical research. The HIT-6 items measure the adverse impact of headache on social functioning, role functioning, vitality, cognitive functioning and psychological distress. The HIT-6 also measures the severity of headache pain. Media Contact Shannon Severino [email protected] SOURCE Neurolens

PHOENIX, Dec. 5, 2023 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $45 million in growth capital to Neurolens, a company commercializing innovative solutions to optimize vision. Neurolens offers the only prescription lenses that use a contoured prism to treat headaches, neck and shoulder pain, and eyestrain caused by eye misalignment. The company recently announced the launch of the N3, a fast and accurate way for eyecare providers to measure eye misalignment down to a fraction of a prism diopter. The company is committed to enhancing patient outcomes and assisting eye care providers in delivering much-needed relief to their patients. "With the introduction of the N3, Neurolens will enable even more eye care professionals to access contoured prism technology in their optometry practices," said Igor DaCruz, Managing Director, Life Sciences at Trinity. "We are thrilled to work with them as they continue changing the lives of patients." This capital will fuel continued growth in the company's operations and is expected to further accelerate the adoption of Neurolens N3 devices in optometry practices across the United States and Canada. "While we continue to experience double-digit growth each year, the unmet patient need remains immense," said Davis Corley, Executive Chairman of Neurolens. "We are committed to leveraging innovative technology like the N3 to remove barriers to adoption and ensure that every eye care professional can access these life-changing outcomes for their patients. We are grateful that Trinity Capital Inc.—along with our dedicated investors—are embracing our mission to transform eye care." About Trinity Capital Inc. Trinity Capital Inc. (Nasdaq: TRIN), an internally managed business development company, is a leading provider of diversified financial solutions to growth-stage companies with institutional equity investors. Trinity Capital's investment objective is to generate current income and, to a lesser extent, capital appreciation through investments, including term loans and equipment financings and equity-related investments. Trinity Capital believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience and track record in lending to growth stage companies. For more information, please visit the Company's website at . About Neurolens Neurolens commercializes breakthrough technology to improve vision care. With patented Contoured Prism technology, Neurolenses are the first and only prescription lenses that go beyond visual acuity to provide comfort for the majority of adults who complain of headaches, neck/shoulder pain and eyestrain when using digital devices, reading or doing detail work. The Neurolens Contoured Prism design helps the eyes work together comfortably, bringing the eyes into alignment to relieve painful symptoms. Technology from Neurolens is only available to Independent Eye Care Providers. To learn more about Neurolens, please visit our website at . SOURCE Trinity Capital Inc.

On the heels of their viral TikTok sensation, the Eyeris 1 Eye Massager, RENPHO launches a new, upgraded version… Along with a brand new aromatherapy sleep mask for all of your self-care needs. SAN FRANCISCO, Sept. 12, 2023 /PRNewswire/ -- Today RENPHO, leading innovator of health and wellness lifestyle solutions, has announced the launch of the Eyeris 3 Eye Massager and EyeSnooze Aroma Sleep Mask. The Eyeris 3 Eye Massager provides an upgraded experience to the company's fan favorite, Eyeris 1 Eye Massager, now with an all-new: removable cooling gel mask, wider eye cushion to massage the temples, and voice commands for hands-free control. While, the EyeSnooze Aroma features black-out sensory blocking, optional heating, aromatherapy, and a comfortable memory foam design to improve sleep quality. For a limited time, both the Eyeris 3 and EyeSnooze Aroma are available as a special introductory bundle offer, here on RENPHO.com. The Eyeris 3 and EyeSnooze Aroma provide the ultimate at-home wellness experience without a hefty price tag. Both products are travel-friendly and designed to enhance users' morning and night routines, by promoting relaxation, alleviating headaches and eye fatigue, reducing dry eyes and dark circles, and boosting sleep quality – even when on the go! This duo offers a spa experience no matter where you are, morning or night. "Customers loved our original eye massager, as the Eyeris 1 took social media by storm, going viral across TikTok and Instagram time and time again," said Jonathon Baggia at RENPHO. "Our R&D Team was tasked with redesigning an even more innovative version of our best-seller inspired by true customer feedback and reviews. Not only did they come up with an improved version of our best-selling eye massager, but they also created the EyeSnooze Aroma Sleep Mask – providing our fans a product duo that will simplify and enhance relaxation for any time of day." RENPHO Eyeris 3 Eye Massager With optional heating functionality and a detachable cooling mask, the RENPHO Eyeris 3 is a 2-in-1 massager that will help relieve headaches, eye fatigue and dry eyes as well as reduce swelling and dark circles, depending on the temperature and massage functions you choose. Additional features include: Newly improved design made to fit all head shapes and sizes with a wider cushion that extends to the temples to accurately target ten different acupressure points. Three-massage and heating modes, and a freezer-friendly cooling gel mask to experience a fully customizable, spa-quality massage in the comfort of your home. Hands-free voice control with up to 18 unique commands. The device also actively remembers custom massage patterns and voice command requests for users to easily repeat favorite combinations and be in full control of their relaxation routine. Near-silent massage motor, less than 43dB, and built-in Bluetooth speakers for listening to your personal music or built-in soothing sounds without interruption. RENPHO EyeSnooze Aroma Sleep Mask The RENPHO EyeSnooze Aroma Sleep Mask combines the benefits of soothing aromatherapy, gentle heating, and complete light & noise blocking for a luxurious sleep and relaxation experience. Additional features include: Three different temperatures, two user-friendly aroma carriers, and built-in Bluetooth speakers for the ultimate sleeping companion, at an accessible price. Memory foam padding design that is washable, with a detachable air sponge cushion you can remove when cleaning. Easy application of your favorite aromatherapy scents; simply drop into the carrier tablets in the front of the mask and enjoy the many potential benefits: improved sleep quality, decreased insomnia, alleviation of eye fatigue and dry eyes, and better management of stress, anxiety, depression, and pain. Both products are available on RENPHO.com today with a limited-time bundle price offering. Also sold separately, the Eyeris 3 Eye Massager is available in a semi-translucent, smoked black color for $199.99, while the EyeSnooze Aroma Sleep Mask comes in a sleek matte black for $69.99. To learn more, visit RENPHO.com or RENPHO on Amazon and follow along on Instagram and TikTok. About RENPHO Founded in 2016, RENPHO was born with the vision to empower people worldwide to improve all aspects of their life by granting a passport to their own health data. Its mission is to create a growing ecosystem of smart lifestyle products that provide advanced solutions which are essential, accessible and everyday. Widely recognized for its smart weight scales and massage products, RENPHO continues to be a leading innovator in health & wellness technology, developing products that are carefully researched to enhance people's health, fitness and wellness journey. To learn more, visit RENPHO.com or follow RENPHO on Instagram, Twitter, Facebook, TikTok and LinkedIn. RENPHO: Smart Health Simplified. Media Contact 5W Public Relations [email protected] [email protected] SOURCE RENPHO